Ramatroban

Ramatroban is a drug that was initially developed for the treatment of allergic diseases such as asthma and allergic rhinitis. It is a thromboxane receptor antagonist, which means it blocks the action of thromboxane, a substance that contributes to inflammation and other allergic reactions.

Etymology

The name "Ramatroban" is derived from the chemical name of the drug, which is "(+)-(3R)-3-[[4-(4-Fluorobenzoyl)-3-(3-oxo-1,2,4-triazol-5-yl)benzyl]oxy]chroman". The "Rama" part of the name is likely derived from the "3R" in the chemical name, while the "troban" part is a common suffix for drugs that are thromboxane receptor antagonists.

Pharmacology

Ramatroban works by blocking the action of thromboxane A2, a substance that is produced in the body and plays a role in inflammation and allergic reactions. By blocking the action of thromboxane A2, Ramatroban can help to reduce inflammation and alleviate the symptoms of allergic diseases.

Clinical uses

Ramatroban is used in the treatment of allergic diseases such as asthma and allergic rhinitis. It can help to reduce the symptoms of these conditions, such as wheezing, shortness of breath, and nasal congestion.

Side effects

Like all drugs, Ramatroban can cause side effects. These may include headache, dizziness, nausea, and diarrhea. If these side effects persist or become severe, patients should contact their healthcare provider.

Related terms

• Thromboxane A2
• Thromboxane receptor antagonist
• Allergic rhinitis
• Asthma

Ramatroban Resources
Latest articles Most recent articles Ongoing trials	Wikipedia